Press Releases

Mithra Pharmaceuticals licht een tipje van de sluier over de noden en verwachtingen van vrouwen rond vrouwelijke gezondheid
7 January 2016
FR NL

Mithra Acquires 100% Rights of Myring and Zoreline® and Closes first Distribution Deal
8 December 2015
EN FR NL

Mithra Pharmaceuticals Reacts to Unfounded Declarations in the Press
3 December 2015
EN FR NL

Mithra neemt nota van de beslissing in kortgeding en zal verder haar rechten doen gelden
1 December 2015
FR NL

Mithra Pharmaceuticals n’a pas censuré Médor
19 November 2015
FR NL

Omkoping van geneesheren : buitenvervolgingstelling van Mithra en haar manager, François Fornieri
18 November 2015
FR NL

Mithra Pharmaceuticals SA/NV Announces the Last Patient Enrollment in the Pharmacodynamics & Pharmacokinetics Studies of the Zoreline® Implant 10.8 mg
18 November 2015
EN FR NL

Mithra Pharmaceuticals Invests EUR 75.2 Million in Flemalle
17 November 2015
EN FR NL

Mithra Pharmaceuticals Selects Chiltern as CRO for the Phase II Clinical Trials of its Product Candidate Donesta®
21 October 2015
EN FR

Mithra Pharmaceuticals Announces Strengthening of its Management Team
1 October 2015
EN FR

New Market Share Record for Mithra Pharmaceuticals in August 2015
30 September 2015
EN FR

Half Year 2015 Results ( Full report )
4 September 2015
EN FR